- Home
- RCON vs CNTB Comparison
RCON vs CNTB Comparison
Compare RCON & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- CNTB
- Stock Information
- Founded
- RCON 2007
- CNTB 2012
- Country
- RCON China
- CNTB United States
- Employees
- RCON N/A
- CNTB N/A
- Industry
- RCON Oilfield Services/Equipment
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- RCON Energy
- CNTB Health Care
- Exchange
- RCON Nasdaq
- CNTB Nasdaq
- Market Cap
- RCON 64.2M
- CNTB 53.9M
- IPO Year
- RCON 2009
- CNTB 2021
- Fundamental
- Price
- RCON $2.45
- CNTB $1.05
- Analyst Decision
- RCON
- CNTB Strong Buy
- Analyst Count
- RCON 0
- CNTB 1
- Target Price
- RCON N/A
- CNTB $8.00
- AVG Volume (30 Days)
- RCON 7.3K
- CNTB 28.0K
- Earning Date
- RCON 01-01-0001
- CNTB 09-05-2024
- Dividend Yield
- RCON N/A
- CNTB N/A
- EPS Growth
- RCON N/A
- CNTB N/A
- EPS
- RCON N/A
- CNTB N/A
- Revenue
- RCON $9,475,055.00
- CNTB $24,116,000.00
- Revenue This Year
- RCON N/A
- CNTB N/A
- Revenue Next Year
- RCON $15.18
- CNTB $63.90
- P/E Ratio
- RCON N/A
- CNTB N/A
- Revenue Growth
- RCON 2.59
- CNTB N/A
- 52 Week Low
- RCON $1.26
- CNTB $0.90
- 52 Week High
- RCON $4.32
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- RCON 59.99
- CNTB 45.74
- Support Level
- RCON $2.14
- CNTB $1.01
- Resistance Level
- RCON $2.40
- CNTB $1.40
- Average True Range (ATR)
- RCON 0.17
- CNTB 0.13
- MACD
- RCON 0.03
- CNTB -0.01
- Stochastic Oscillator
- RCON 62.71
- CNTB 25.53
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.